Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 461

1.

Aplastic anemia.

Čermák J.

Vnitr Lek. 2018 Summer;64(5):501-507.

PMID:
30193518
2.

Eltrombopag Improves Refractory Thrombocytopenia in a Patient with Systemic Lupus Erythematosus.

Shima N, Sumida K, Kawada M, Sekine A, Yamanouchi M, Hiramatsu R, Hayami N, Hasegawa E, Suwabe T, Hoshino J, Sawa N, Takaichi K, Ohashi K, Fujii T, Ubara Y.

Case Rep Rheumatol. 2018 Aug 15;2018:6305356. doi: 10.1155/2018/6305356. eCollection 2018.

3.

Severe immune thrombocytopenia in pregnancy treated with Eltrombopag - A case report.

Ferreira IJMCF, Sousa F, Vasco EM, Areia ALFA, Moura JPAS, Carda J, Ribeiro L.

J Gynecol Obstet Hum Reprod. 2018 Oct;47(8):405-408. doi: 10.1016/j.jogoh.2018.06.010. Epub 2018 Jul 4.

PMID:
29981476
4.

[Acquired aplastic anemia: recent advances in pathophysiology and treatment].

Yamazaki H.

Rinsho Ketsueki. 2018;59(6):711-715. doi: 10.11406/rinketsu.59.711. Japanese.

PMID:
29973449
5.

Therapeutic Doses of Eltrombopag do not Inhibit Hepatic BCRP in Healthy Volunteers: Intravenous Ceftriaxone as a Model.

Neves DV, Vieira CP, Rocha A, Lanchote VL.

J Pharm Pharm Sci. 2018;21(1):236-246. doi: 10.18433/jpps29856.

6.

Risk of thrombosis with anti-phospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists.

Guitton Z, Terriou L, Lega JC, Nove-Josserand R, Hie M, Amoura Z, Bussel JB, Hamidou M, Rosenthal E, Lioger B, Chauveau D, Chaminade A, Magy-Bertrand N, Michel M, Audia S, Godeau B, Mahevas M.

Rheumatology (Oxford). 2018 Aug 1;57(8):1432-1438. doi: 10.1093/rheumatology/key119.

PMID:
29757439
7.

Treatment characteristics, efficacy and safety of thrombopoietin analogues in routine management of primary immune thrombocytopenia.

Mingot-Castellano ME, Caparrós IS, Fernández F, Perera-Alvarez MDM, Jimenez-Bárcenas R, Casaus García A, González-Silva M, Yera-Cobo M, Nieto-Hernandez MM, Rodríguez-Fernandez MJ, Díaz-Canales D.

Blood Coagul Fibrinolysis. 2018 Jun;29(4):374-380. doi: 10.1097/MBC.0000000000000726.

PMID:
29738335
8.

Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.

Busca A, Dellacasa C, Giaccone L, Manetta S, Biale L, Godio L, Aydin S, Festuccia M, Brunello L, Bruno B.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1765-1770. doi: 10.1016/j.bbmt.2018.04.022. Epub 2018 Apr 21.

PMID:
29684566
9.

Eltrombopag-Induced Acute Liver Failure in a Pediatric Patient: A Pharmacokinetic and Pharmacogenetic Analysis.

Marano M, Serafinelli J, Cairoli S, Martinelli D, Pisani M, Palumbo G, Cefalo MG, Cecchetti C, Di Nardo M, Falvella FS, Goffredo BM.

Ther Drug Monit. 2018 Aug;40(4):386-388. doi: 10.1097/FTD.0000000000000522.

PMID:
29683873
10.

[Neutrophil recovery by eltrombopag treatment in a patient with adult-onset autoimmune neutropenia and immune thrombocytopenia].

Tokunaga M, Yamada M, Kondo A, Mishima M, Yoshikawa S, Inoue S, Morita T, Tominaga N.

Rinsho Ketsueki. 2018;59(3):310-314. doi: 10.11406/rinketsu.59.310. Japanese.

PMID:
29618690
11.

[The efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia].

Huang YT, Liu XF, Chen YF, Fu RF, Liu W, Zhang L, Yang RC.

Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):32-36. doi: 10.3760/cma.j.issn.0253-2727.2018.01.007. Chinese.

PMID:
29551030
12.

Eltrombopag in the management of aplastic anaemia: real-world experience in a non-trial setting.

Hwang YY, Gill H, Chan TSY, Leung GMK, Cheung CYM, Kwong YL.

Hematology. 2018 Aug;23(7):399-404. doi: 10.1080/10245332.2017.1422306. Epub 2018 Jan 5.

PMID:
29303047
13.

Eltrombopag with i.v. immunoglobulin for safe splenectomy in refractory immune thrombocytopenia.

Kanno M, Onoda T, Meguro T, Sato H, Mitsui T.

Pediatr Int. 2018 Feb;60(2):191-192. doi: 10.1111/ped.13446. Epub 2017 Dec 22. No abstract available.

PMID:
29271533
14.

Thrombopoietin receptor agonists in patients with persistent or chronic immune thrombocytopenia.

Agnelli Giacchello J, Valeri F, Boccadoro M, Borchiellini A.

Eur J Haematol. 2018 Mar;100(3):304-307. doi: 10.1111/ejh.13014. Epub 2018 Jan 15.

PMID:
29243329
15.

Eltrombopag for advanced myelodysplastic syndromes or acute myeloid leukaemia and severe thrombocytopenia (ASPIRE): a randomised, placebo-controlled, phase 2 trial.

Mittelman M, Platzbecker U, Afanasyev B, Grosicki S, Wong RSM, Anagnostopoulos A, Brenner B, Denzlinger C, Rossi G, Nagler A, Garcia-Delgado R, Portella MSO, Zhu Z, Selleslag D.

Lancet Haematol. 2018 Jan;5(1):e34-e43. doi: 10.1016/S2352-3026(17)30228-4. Epub 2017 Dec 11.

PMID:
29241762
16.

A low birth weight infant with no malformations delivered by a primary immune thrombocytopenia patient treated with eltrombopag.

Suzuki N, Hiraga J, Hariyama Y, Takagi Y, Ohashi H, Kishigami Y, Oguchi H, Kagami Y.

Int J Hematol. 2018 Jul;108(1):109-111. doi: 10.1007/s12185-017-2383-1. Epub 2017 Nov 29.

PMID:
29188582
17.

Efficacy of bendamustine on thrombocytopenia and hemolytic anemia secondary to CD5-positive B-cell lymphoma with massive splenomegaly in a patient with rheumatoid arthritis.

Hosoda Y, Hagino H, Hino N, Motokura T.

Mol Clin Oncol. 2017 Nov;7(5):855-858. doi: 10.3892/mco.2017.1425. Epub 2017 Sep 19.

18.

Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.

Zhang X, Chuai Y, Nie W, Wang A, Dai G.

Cochrane Database Syst Rev. 2017 Nov 27;11:CD012035. doi: 10.1002/14651858.CD012035.pub2. Review.

PMID:
29178132
19.

[Novelties in the treatment of pediatric immune thrombocytopenia - 2017].

Kovács G, Kiss C.

Orv Hetil. 2017 Dec;158(48):1891-1896. doi: 10.1556/650.2017.30934. Hungarian.

PMID:
29172661
20.

Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia.

Lengline E, Drenou B, Peterlin P, Tournilhac O, Abraham J, Berceanu A, Dupriez B, Guillerm G, Raffoux E, de Fontbrune FS, Ades L, Balsat M, Chaoui D, Coppo P, Corm S, Leblanc T, Maillard N, Terriou L, Socié G, de Latour RP.

Haematologica. 2018 Feb;103(2):212-220. doi: 10.3324/haematol.2017.176339. Epub 2017 Nov 23.

Supplemental Content

Loading ...
Support Center